Structure (Sumainjvial Figure 01)
Sumatriptan Succinate
Product Images NDC 55648-728
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 55648-728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Sumainjvial Figure 02)
Vial Label (Sumainjvial Figure 03)
This is a description of a medicine called Sumatriptan Succinate Injection. It comes in a 0.5 mL single-dose vial with NDC (National Drug Code) 64679728. Each vial contains 6mg of sumatriptan and is intended for subcutaneous (under the skin) injection only. The label displays some symbols such as "Non Vamish Arga - Reonty Koo" which is not clear what their significance is. The packaging also shows the dimensions of the vial which are 16.5 mm x 7 mm. There is also a code on the packaging which reads "PAIG MOIBIEM 07".*
Vial Carton (Sumainjvial Figure 04)
This is a package insert for Sumatriptan Succinate Injection, a medication used for subcutaneous injection to treat migraines. It contains 6 mg of sumatriptan and 3.5 mg of sodium chloride per 0.5 mL of solution. The medication needs to be stored between 2° and 25°C (36° and 77°F) and protected from light. The package contains 5 single-dose vials of 0.5 mL each. The medication is manufactured by Wocknardt Limited in India and distributed by Wocknardt USA LLC. Dosage and administration instructions are provided in the package insert, and any unused medication needs to be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
